Simple, Highly Enantioselective Access to Quaternary 1,3,4,4-Tetrasubstituted b-Lactams
FULL PAPERS
[6] For examples of human leukocyte elastase inhibitors,
see: a) R. Moreira, A. B. Santana, J. Iley, J. Neres, K. T.
Douglas, P. N. Horton, M. B. Hursthouse, J. Med.
Chem. 2005, 48, 4861–4870; b) C. Saturnino, M. Buo-
nerba, A. Capasso, Lett. Drug Des. Discov. 2007, 4,
484–486.
[7] For b-lactam-based HCMV inhibitors, see: a) C.
Yoakim, W. Ogilvie, D. R Cameron, C. Chabot, I.
Guse, B. HachØ, J. Naud, J. A. OꢁMeara, R. Plante, R.
DØziel, J. Med. Chem. 1998, 41, 2882–2892; b) G.
Gerona-Navarro, M. J. PØrez de Vega, M. T. García-
López, G. Andrei, R. Snoeck, E. De Clercq, J. Balzari-
ni, R. Gonzµlez-MuÇiz, Bioorg. Med. Chem. Lett. 2004,
14, 2253–2256; c) G. Gerona-Navarro, M. J. PØrez
de Vega, M. T. García-López, G. Andrei, R. Snoeck, E.
De Clercq, J. Balzarini, R. Gonzµlez-MuÇiz, J. Med.
Chem. 2005, 48, 2612–2621.
[8] Ezetimibe and analogues: a) J. W. Clader, Curr. Top.
Med. Chem. 2005, 5, 243–256; b) L. Kvaerno, M.
Werder, H. Houser, E. M. Carreira, J. Med. Chem.
2005, 48, 6035–6053.
[9] G. Veinberg, M. Vorona, I. Shestakova, I. Kanepe, E.
Lukevics, Curr. Med. Chem. 2003, 10, 1741–1757.
[10] D. Kuhn, C. Coates, K. Daniel, D. Chen, M. Bhuiyan,
A. Kazi, E. Turos, Q. P. Dou, Front. Biosci. 2004, 9,
2605–2617.
536; e) L. MØndez, S. A. Testero, E. G. Mata, J. Comb.
Chem. 2007, 9, 189–192.
[17] For asymmetric solid-phase versions of the Staudinger
reaction, see: a) K. Gordon, M. Bolger, N. Khan, S. Ba-
lasubramanian, Tetrahedron Lett. 2000, 41, 8621–8625;
b) C. M. L. Delpiccolo, M. M. Fraga, E. G. Mata, J.
Comb. Chem. 2003, 5, 208–210; c) C. M. L. Delpiccolo,
L. M. MØndez, M. M. Fraga, E. G. Mata, J. Comb.
Chem. 2005, 7, 331–344, and references cited therein.
[18] Examples of NH b-lactams through Staudinger reac-
tion: a) K. H. Gordon, S. Balasubramanian, Org. Lett.
2001, 3, 53–56; b) S. K. Dasgupta, B. K. Banik, Tetrahe-
dron Lett. 2002, 43, 9445–9447.
[19] M. M. Meloni, M. Taddei, Org. Lett. 2001, 3, 337–340.
[20] S. Schunk, D. Enders, J. Org. Chem. 2002, 67, 8034–
8042.
[21] Solution synthesis of 1,4,4-trisubstituted b-lactams:
a) G. Gerona-Navarro, M. A. Bonache, R. Herranz,
M. T. García-López, R. Gonzµlez-MuÇiz, Synlett 2000,
1249–1252; b) G. Gerona-Navarro, M. A. Bonache, R.
Herranz, M. T. García-López, R. Gonzµlez-MuÇiz, J.
Org. Chem. 2001, 66, 3538–3547; c) G. Gerona-Navar-
ro, M. A. Bonache, N. Reyero, M. T. García-López, R.
Gonzµlez-MuÇiz, Heterocycles 2002, 57, 501–513; d) G.
Gerona-Navarro, M. T. García-López, R. Gonzµlez-
MuÇiz, J. Org. Chem. 2002, 67, 3953–3956.
[11] B. Alcaide, P. Almendros, C. Aragoncillo, Chem. Rev.
2007, 107, 4437–4492.
[12] C. Palomo, J. M. Aizpurua, I. Ganboa, M. Oiarbide,
[22] Solid-phase approach to 1,4,4-trisubstituted b-lactams:
G. Gerona-Navarro, M. Royo, M. T. García-López, F.
Albericio, R. Gonzµlez-MuÇiz, Mol. Divers. 2003, 6,
75–84.
Curr. Med. Chem. 2004, 11, 1837–1872.
[13] For outstanding examples of b-lactams as turn inducers,
see a) C. Palomo, J. M. Aizpurua, E. Balentova, A. Ji-
mØnez, J. Oyarbide, R. M. Fratila, J. I. Miranda, Org.
Lett. 2007, 9, 101–104; b) A. Macias, A. M. Ramallal,
E. Alonso, C. del Pozo, J. Gonzµlez, J. Org. Chem.
2006, 71, 7721–7730; c) T. C. Maier, W. U. Frey, J. Pod-
lech, Eur. J. Org. Chem. 2002, 2686–2688; d) A. B.
Khasanov, M. M. Ramirez-Weinhouse, T. R. Webb, M.
Thiruvazhi, J. Org. Chem. 2004, 69, 5766–5769; e) H.
Bittermann, F. Boeckler, J. Einsiedel, P. Gmeiner,
Chem. – A Eur. J. 2006, 12, 6315–6322.
[14] For recent reviews on the synthesis of b-lactam deriva-
tives, see: a) P. A. Magriotis, Angew. Chem. Int. Ed.
2001, 40, 4377–4379; b) G. S. Singh, Tetrahedron 2003,
59, 7631–7649; c) S. France, A. Weatherwax, A. E.
Taggi, T. Lectka, Acc. Chem. Res. 2004, 37, 592–600.
[15] M. A. Laborde, E. G. Mata, Mini-Rev. Med. Chem.
2006, 6, 109–120.
[23] P. PØrez-Faginas, F. OꢁReilly, A. OꢁByrne, C. García-
Aparicio, M. Martín-Martínez, M. J. PØrez de Vega,
M. T. García-López, R. Gonzµlez-MuÇiz, Org. Lett.
2007, 9, 1593–1596.
[24] P. PØrez-Faginas, I. Alkorta, M. T. García-López, R.
Gonzµlez-MuÇiz, Tetrahedron Lett. 2008, 49, 215–218.
[25] 1-Indolylcarbaldehyde and pivalaldehyde, initially se-
lected within the set of aldehydes, were finally discard-
ed due to insolubility in the methyl orthoformiate sol-
vent, in the first case, and to the lack of acylation of
the formed N-tert-butylmethylamino acid resins, in the
second one, respectively.
[26] A. K. Szardenings, T. S. Burtoth, G. C. Look, D. A.
Campbell, J. Org. Chem. 1996, 61, 6720–6722.
[27] W. Pluempanupat, O. Chantarasriwong, P. Taboonpong,
D. Jang, W. Chavarisi, Tetrahedron Lett. 2007, 48, 223–
226.
[28] M. Feroci, Adv. Synth. Catal. 2007, 349, 2177–2181.
[29] A. Nefzi, J. M. Ostresh, J. Yu, R. A. Houghten, J. Org.
Chem. 2004, 69, 3603–3609.
[30] G. Gerona-Navarro, M. A. Bonache, M. Alías, M. J.
PØrez de Vega, M. T García-López, P. López, C. Cati-
viela, R. Gonzµlez-MuÇiz, Tetrahedron Lett. 2004, 45,
2193–2196.
[16] For solid-phase Staudinger strategies leading to racemic
b-lactams, see: a) B. Ruhland, A. Bhandari, E. M.
Gordon, M. A. Gallop, J. Am. Chem. Soc. 1996, 118,
253–254; b) R. Singh, J. M. Nuss, Tetrahedron Lett.
1999, 40, 1249–1252; c) C. M. L. Delpiccolo, E. G.
Mata, Tetrahedron Lett. 2004, 45, 4085–4088; d) W.-G.
Shou, Y.-Y. Yang, Y.-G. Wang, Synthesis 2005, 530–
Adv. Synth. Catal. 2008, 350, 2279 – 2285
ꢀ 2008 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
2285